Results 221 to 230 of about 1,230,780 (305)

A Chinese adaptation of the Patient Health Questionnaire for Adolescents (PHQ-A): factor structure and psychometric properties. [PDF]

BMC Psychiatry
Chen YQ, Huang XJ, Yang F, Yang JJ, Zhong J, Yao KM, Kuang JX, Xu MZ.   +7 more
europepmc   +1 more source

Local Specific IgE Levels Can Predict and Monitor the Therapeutic Response to Subcutaneous Immunotherapy With House Dust Mite

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Identifying predictive and monitoring biomarkers for allergen immunotherapy response is crucial for enhancing clinical efficacy. This study aims to investigate the systemic and local levels of immunoglobulins and identify potential biomarkers in house dust mite (HDM) allergic rhinitis (AR) patients who are undergoing subcutaneous ...
Xu Xu, Jingyun Li, Xu Zhang, Yu Song, Lin Xi, Luo Zhang, Yuan Zhang   +6 more
wiley   +1 more source

Risk for Suicide Attempts Assessed Using the Patient Health Questionnaire-9 Modified for Teens.

JAMA Netw Open
Tsui F, Ruiz VM, Ryan ND, Shi L, Melhem NM, Young JF, Davis M, Gibbons R, Brent DA.   +8 more
europepmc   +1 more source

Impedance‐Controlled Multipoint Radiofrequency Ablation for Chronic Rhinitis: A Randomized Controlled Trial

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background The purpose of this randomized controlled trial (RCT) was to demonstrate that posterior nasal nerve ablation treatment with the NEUROMARK System is superior to a sham control procedure in patients with chronic rhinitis. Methods In this prospective, multicenter, single‐blinded, superiority RCT, 132 participants were randomized 2:1 to
Masayoshi Takashima, Randall A. Ow, Richard D. Thrasher, Ellen M. O'Malley, William R. Blythe, Omar G. Ahmed   +5 more
wiley   +1 more source

Disease Progression in Multiple System Atrophy: The ASPIRE Multi‐Modal Biomarker Study

Annals of Neurology, EarlyView.
Objective The objective of this study was to characterize changes in candidate biomarkers in early multiple system atrophy (MSA) and identify baseline predictors of faster progression. Methods This 1‐year, multicenter, prospective study assessed clinical, neuroimaging (3T‐magnetic resonance imaging [MRI], dopamine transporter single‐photon emission ...
Margherita Fabbri, Natalia del Campo, Wassilios G. Meissner, Vanessa Rousseau, Agnès Sommet, Pierre Payoux, Pierre Gantet, Amel Drif, Hélène Catalá, Claire Thalamas, Christine Tranchant, Franck Durif, Ana Marques, Alexandre Eusebio, Luc Defebvre, Jean‐Christophe Corvol, Stéphane Thobois, Anthime Flaus, Anne‐Gaelle Corbille, Solène Frismand, Beverley Patterson, Alexandra Foubert‐Samier, Anne Pavy‐Le Traon, Germain Arribarat, Patrice Péran, Olivier Rascol, for the ASPIRE Study Group   +26 more
wiley   +1 more source

Implementing Patient Health Questionnaire Depression Screening in Inflammatory Arthritis Clinic: Insights From a Quality Improvement Project at a Tertiary Rheumatology Center. [PDF]

ACR Open Rheumatol
Yu JM, Goodman S, Rakowicz AM, Bugante J, Lee JI.   +4 more
europepmc   +1 more source

Measuring motor function of children with mild/moderate intellectual impairment using the HiMAT/ Revised HiMAT compared to BOT2: a pilot validation study [PDF]

, 2011
Gunther, Dominic, Keogh, Helen, Low Choy, Nancy, Milne, Nikki, Richmond, Joy, Steele, Mike   +5 more
core  

Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas

Annals of Neurology, EarlyView.
Objective Mitogen‐activated protein kinase kinase inhibitors have shown promising results in treatment of plexiform neurofibromas in neurofibromatosis type 1 patients, but data in adults are limited. The aim of this phase 2 study was to investigate the efficacy and safety of trametinib in adults with neurofibromatosis type 1.
D. Christine Noordhoek, David F. Hanff, Pim J. French, Sarah A. van Dijk, Erik A.C. Wiemer, Olivier C. Manintveld, Martin J. van den Bent, Walter Taal   +7 more
wiley   +1 more source

Data-Driven Cutoff Selection for the Patient Health Questionnaire-9 Depression Screening Tool.

JAMA Netw Open
Levis B, Bhandari PM, Neupane D, Fan S, Sun Y, He C, Wu Y, Krishnan A, Negeri Z, Imran M, Rice DB, Riehm KE, Azar M, Levis AW, Boruff J, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, Patten SB, Ziegelstein RC, Harel D, Takwoingi Y, Markham S, Alamri SH, Amtmann D, Arroll B, Ayalon L, Baradaran HR, Beraldi A, Bernstein CN, Bhana A, Bombardier CH, Buji RI, Butterworth P, Carter G, Chagas MH, Chan JCN, Chan LF, Chibanda D, Clover K, Conway A, Conwell Y, Daray FM, de Man-van Ginkel JM, Fann JR, Fischer FH, Field S, Fisher JRW, Fung DSS, Gelaye B, Gholizadeh L, Goodyear-Smith F, Green EP, Greeno CG, Hall BJ, Hantsoo L, Härter M, Hides L, Hobfoll SE, Honikman S, Hyphantis T, Inagaki M, Iglesias-Gonzalez M, Jeon HJ, Jetté N, Khamseh ME, Kiely KM, Kohrt BA, Kwan Y, Lara MA, Levin-Aspenson HF, Liu SI, Lotrakul M, Loureiro SR, Löwe B, Luitel NP, Lund C, Marrie RA, Marsh L, Marx BP, McGuire A, Mohd Sidik S, Munhoz TN, Muramatsu K, Nakku JEM, Navarrete L, Osório FL, Pence BW, Persoons P, Petersen I, Picardi A, Pugh SL, Quinn TJ, Rancans E, Rathod SD, Reuter K, Rooney AG, Santos IS, Schram MT, Shaaban J, Shinn EH, Sidebottom A, Simning A, Spangenberg L, Stafford L, Sung SC, Suzuki K, Tan PLL, Taylor-Rowan M, Tran TD, Turner A, van der Feltz-Cornelis CM, van Heyningen T, Vöhringer PA, Wagner LI, Wang JL, Watson D, White J, Whooley MA, Winkley K, Wynter K, Yamada M, Zeng QZ, Zhang Y, Thombs BD, Benedetti A, Depression Screening Data (DEPRESSD) PHQ Group.   +127 more
europepmc   +1 more source